<?xml version='1.0' encoding='utf-8'?>
<section xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude">
  <num>31-3834.03</num>
  <heading>Coverage of additional preventive health services.</heading>
  <para>
    <num>(a)</num>
    <text>Health insurance coverage through Medicaid or the D.C. Healthcare Alliance program shall also provide coverage for and shall not impose any cost-sharing requirements for the following:</text>
    <para>
      <num>(1)</num>
      <text>Voluntary sterilization procedures for women;</text>
    </para>
    <para>
      <num>(2)</num>
      <para>
        <num>(A)</num>
        <text>All contraceptive products approved by the U.S. Food and Drug Administration ("FDA"), including emergency contraception; provided, that:</text>
      </para>
      <para>
        <num>(B)</num>
        <text>If there is a therapeutic equivalent of an FDA-approved contraceptive drug, device, or product, coverage shall also include either the original FDA-approved contraceptive drug, device, or product or at least one of its therapeutic equivalents, without imposing any cost-sharing requirements;</text>
      </para>
      <para>
        <num>(C)</num>
        <text>If the covered contraceptive drug, device, or product is deemed medically inadvisable by a provider, the health insurer shall defer to the determination and judgment of the attending provider and provide coverage for the alternative prescribed contraceptive drug, device, or product without imposing any cost-sharing requirements; and</text>
      </para>
      <para>
        <num>(D)</num>
        <text>Nothing in this section shall prohibit a health insurer from requiring the use of a generic prescription drug when providing coverage for preventive contraceptive services, so long as such health insurer:</text>
        <para>
          <num>(i)</num>
          <text>Has a process for a member to seek medically necessary coverage of a covered brand name contraceptive drug as determined by the member's prescribing provider; and</text>
        </para>
        <para>
          <num>(ii)</num>
          <text>Provides coverage for a brand name contraceptive drug when there is no generic substitute available in the market;</text>
        </para>
      </para>
    </para>
    <para>
      <num>(3)</num>
      <text>Contraceptive services including consultation with a pharmacist, patient education, and counseling on contraception; and</text>
    </para>
    <para>
      <num>(4)</num>
      <text>Follow-up services related to the drugs, devices, products, and procedures covered under this section, including management of side effects, counseling for continued adherence, and device insertion and removal.</text>
    </para>
  </para>
  <para>
    <num>(b)</num>
    <text>Beginning on January 1, 2019, or the next date when carrier forms are approved, whichever is earlier, an individual health plan or group health plan shall also provide coverage for and shall not impose any cost-sharing requirements for all products and services listed in subsection (a) of this section.</text>
  </para>
  <annotations>
    <annotation doc="D.C. Law 13-254" type="History" path="ยง5c">Apr. 3, 2001, D.C. Law 13-254, ยง 5c </annotation>
    <annotation app="2018-01-31" doc="D.C. Act 22-246" eff="2018-01-31" path="ยง3|(b)" prefix="as added" type="History"/>
  </annotations>
</section>
